Privia Health Group, Inc.
General ticker "PRVA" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $2.9B (TTM average)
Privia Health Group, Inc. follows the US Stock Market performance with the rate: 1.3%.
Estimated limits based on current volatility of 1.7%: low 21.86$, high 22.60$
Factors to consider:
- Total employees count: 1226 (+7.5%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Litigation risks, Economic downturns and volatility, VBC arrangements, Payer cost controls
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [20.20$, 31.80$]
- 2026-12-31 to 2027-12-31 estimated range: [20.08$, 31.96$]
Financial Metrics affecting the PRVA estimates:
- Positive: with PPE of 140.3 at the end of fiscal year the price was neutral
- Positive: 0.56 < Operating profit margin, % of 1.61
- Positive: -51.61 < Industry operating profit margin (median), % of -17.21
- Positive: 4.90 < Operating cash flow per share per price, % of 5.61
- Positive: Interest expense per share per price, % of 0 <= 0
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.11
- Negative: Return on assets ratio (scaled to [-100,100]) of 2.12 <= 3.48
- Negative: negative Industry operating cash flow (median)
Short-term PRVA quotes
Long-term PRVA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,657.74MM | $1,736.39MM | $2,122.84MM |
| Operating Expenses | $1,637.09MM | $1,719.41MM | $2,088.61MM |
| Operating Income | $20.65MM | $16.98MM | $34.23MM |
| Non-Operating Income | $8.37MM | $10.89MM | $9.70MM |
| Income(Loss) | $29.02MM | $27.87MM | $43.94MM |
| Taxes | $7.99MM | $10.83MM | $14.21MM |
| Net Income(Loss)* | $23.08MM | $14.38MM | $22.92MM |
| Stockholders Equity | $561.44MM | $635.18MM | $737.22MM |
| Assets | $999.90MM | $1,135.78MM | $1,369.38MM |
| Operating Cash Flow | $80.78MM | $109.28MM | $163.40MM |
| Capital expenditure | $0.11MM | $5.02MM | $1.20MM |
| Investing Cash Flow | $-42.97MM | $-11.98MM | $-181.57MM |
| Financing Cash Flow | $3.71MM | $4.33MM | $6.70MM |
| Earnings Per Share** | $0.20 | $0.12 | $0.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.